The top five tweets: From the BIA to breast cancer — what did EPM readers rate this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

5. FDA’s expansion of the use of Lynparza for breast cancer with specific inhibited genetic mutation is on our list at number five.

4. Fourth position for the week is the news that Systech has expanded its European presence to help with EU FMD preparations.

3. 3P innovation’s plans to expand UK operations makes it into third place.

2. Runner up in this week’s Top Five goes to Desktop Genetics’ announcement that it has received the worldwide licensing rights to CRISPR efficiency web tool.

1. Number one this week is the news that the BIA has been granted permission to intervene in a Supreme Court case.